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Abstract
Background
Acute stress drives a ‘high-alert’ response in the immune system. Psychoactive drugs
induce distinct stress hormone profiles, offering a sought-after opportunity to dissect the in
vivo immunological effects of acute stress in humans.
Methods
3,4-methylenedioxymethamphetamine (MDMA), methylphenidate (MPH), or both, were
administered to healthy volunteers in a randomized, double-blind, placebo-controlled cross-
over-study. Lymphocyte subset frequencies, natural killer (NK) cell immune-phenotypes,
and changes in effector function were assessed, and linked to stress hormone levels and
expression of CD62L, CX3CR1, CD18, and stress hormone receptors on NK cells.
Results
MDMA/MPH >MDMA >MPH robustly induced an epinephrine-dominant stress response.
Immunologically, rapid redistribution of peripheral blood lymphocyte-subsets towards phe-
notypically mature NK cells occurred. NK cytotoxicity was unaltered, but they expressed
slightly reduced levels of the activating receptor NKG2D. Preferential circulation of mature
NK cells was associated with high epinephrine receptor expression among this subset, as
well as expression of integrin ligands previously linked to epinephrine-induced endothelial
detachment.
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Conclusion
The acute epinephrine-induced stress response was characterized by rapid accumulation
of mature and functional NK cells in the peripheral circulation. This is in line with studies
using other acute stressors and supports the role of the acute stress response in rapidly
mobilizing the innate immune system to counteract incoming threats.
Introduction
The response of the body to stress consists in the complex integration of endocrine, neuro-cog-
nitive and immunologic adaptations [1]. Chronic persistent stress has been linked to sup-
pressed immune function and increased susceptibility to infections and cancer [1–4], while
acute stress induces a fight-or-flight reaction, tuned to rapidly respond to injury and subse-
quent entry of infectious agents into the organism. Acute stress-induced changes in the
immune system thus plausibly aim at accelerating wound repair, help prevent infections, and
should occur very rapidly [1].
In contrast to adaptive immunity, the innate immune response is optimized to immediately
respond to pathogens without need for prior cognate exposure. Natural Killer (NK) cells repre-
sent 5–15% of all lymphocytes in the peripheral blood and are important in the defense against
viruses and tumors. Based on their CD56 surface expression-density they can by divided into
cytotoxic CD56dim NK cells (roughly 90%), and the immunomodulatory CD56bright NK cells
(approximately 10% of NK in the peripheral blood). Circulating cytotoxic CD56dim NK cells
detect virally infected or malignantly transformed cells. Their activation results in target cell
lysis and the secretion of cytokines [5]. Previous studies found a strong increase of circulating
NK cells upon stress, suggesting a potential role for NK cells in this context [6].
Stress hormones, including glucocorticoids and catecholamines, are key modulators of
stress-induced immune-dysregulation [7, 8]. However, inter-individual differences in the
endocrine responses often hinder subtle stress-associated immunologic alterations to become
apparent. Thus, a well-controlled experimental model triggering a homogeneous endocrine
stress response should allow to better study how stress impacts the immune system.
3,4-Methylenedioxymethamphetamine (MDMA, “ecstasy”) and methylphenidate (MPH,
“Ritalin1”) are widely used psychoactive substances that induce an endocrine and cardiovascu-
lar stress response that has been extensively studied [9–12]. Previous murine and human stud-
ies suggested that MDMA impacts both the innate and the adaptive immune responses [13,
14]. Data regarding the effect of MPH on the immune system are sparse. Both drugs result in
an increase in norepinephrine levels, i.e. have sympathomimetic effects. While MDMA
enhances serotonergic neurotransmission [15] and increases cortisol levels [11], MPH elevates
dopamine concentrations but has no serotonergic effects [16], and does not increase cortisol
levels [11]. Thus, both MDMA and MPH share sympathomimetic and psychostimulant effects,
yet with distinct hormone profiles.
Here we used drug-induced stress to test its effects on the human immune system. Specifically,
we studied stress hormone-mediated recruitment of NK cell subsets in the context of a random-
ized, double-blind, placebo-controlled clinical trial of subjects receiving MDMA and/or MPH.
Materials and Methods
Clinical study
Healthy subjects (n = 12, mean age 24.9 years, 8 female, 4 male) from a pharmacological
study (NCT01465685) on the effects of single-dose MDMA (125 mg), MPH (60 mg) or a
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combination of the two drugs were tested for the effects of the drugs on the immune system.
Characteristics of the study and the participants have previously been published [12]. All
subjects provided written informed consent. The study was approved by the ethics committee
of the canton of Basel, Switzerland (EKBB 228/11) and conducted in accordance with the
Declaration of Helsinki. All subjects received each drug condition once in a double-blind, pla-
cebo-controlled, crossover design with four experimental test sessions (placebo–placebo,
MPH–placebo, placebo–MDMA, and MPH–MDMA). Drugs were taken orally. Washout peri-
ods between two conditions were at least 10 days. All blood draws were performed via an
indwelling intravenous catheter placed in an antecubital vein and the baseline blood draw was
at 8 am for all study subjects. Peripheral blood mononuclear cells (PBMC) were isolated using
LymphoprepTM (Axis-Shield, Oslo, Norway) density centrifugation and cryopreserved until
use, in order to be able to measure all study timepoints (i.e. conditions) for each subject on the
same day. The cardiovascular stress response (systolic blood pressure and heart rate) was
repeatedly recorded and plasma levels of norepinephrine, epinephrine, dopamine and cortisol
were determined before and 2h after drug administration [12].
Flow cytometry based immunophenotyping
PBMC were immunophenotyped using the following antibodies: CD3-PerCP (UCHT1),
CD4-APC (OKT4), CD18-PE (TS1/18), CD19-PE (HIB19), NKG2D-APC (1D11),
CX3CR1-FITC (2A9-1, all Biolegend), CD3-Pacific Blue (UCHT1), CD8-FITC (HIT8a),
CD16-PE-Cy5 (3G8), CD56-PE, -Alexa Fluor 647 or -PE-Cy7 (B159), CD69-FITC (FN50) (all
BD Biosciences), CD62L-FITC (LT-TD180) (ImmunoTools), GCR-Alexa Fluor 488 (D8H2)
(Cell Signaling Technology) and ADRB2 pure (S364, RayBiotech). The antibody against
ADRB2 was coupled to R-phycoerythrin (RPE) in house using the ABSelect BSA Removal Kit
to clean and concentrate the pure ADRB2 antibody followed by fluorochrome coupling with
the Lightning-Link1 R-Phycoerythrin Conjugation Kit according to manufacturer’s instruc-
tions (Innova Biosciences).
All stainings were performed as surface-stainings for 30 min. at 4°C, with exception of the
intracellular GCR staining that was performed in whole blood according to a standard ICS pro-
tocol (Cell Signaling Technology). All sample acquisitions were performed on an AccuriTM C6
(immune cell subsets and NK function) or a LSRFortessaTM (NK receptor phenotyping) flow
cytometer (BD Biosciences).
NK cell in vitro stimulation assays
NK cell function was assessed by IFNγ production and degranulation (CD107a) as an indirect
marker of cytotoxicity [17]. NK cells were stimulated with K562 cells by co-culture of 106
PBMC at a 10:1 effector-to-target ratio as previously described [18]. Following 30 min. of pre-
incubation, cells were incubated during 4 hours in the presence of Brefeldin A (Biolegend) at
0.5 μg/mL, Monensin (Golgi-StopTM, BD Biosciences) at 0.3 μg/mL and anti-CD107a-APC
(H4A3) (BD Bioscience). Cells were then surface-stained using anti-CD3 PerCP and anti-
CD56 PE followed by intracellular staining for IFNγ using Cytofix/CytopermTM (BD Biosci-
ences) and anti-IFNγ-FITC (4S.B3) (Biolegend). For experiments testing the impact of stress
hormones on NKG2D expression in vitro, cells were incubated for 3 h in serum-free RPMI
1640 (Life Technologies) in the presence of cortisol (Sigma) at 280 ng/mL, epinephrine (Sinte-
tica) at 50 pg/mL, or a combination of both and NKG2D mean fluorescence intensity (MFI)
was assessed.
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Hormone receptor quantification on NK cell subsets using real-time RT
PCR
The β2-adrenergic receptor (ADRB2) and the glucocorticoid receptor (GCR) expression on NK
cell subsets were quantified by real-time PCR. CD56bright and CD56dim NK cells were sorted on a
FACSAriaTM III (BD Bioscience) and RNA was extracted using the QIAamp1 RNA Blood Mini
Kit (Qiagen). Genomic DNA was removed and first-strand cDNA was generated by means of
GoScriptTM Reverse Transcription System (Promega). RT-PCR was performed with GoTaq1
qPCRMaster Mix in duplicates in a 7500 Fast Real-Time PCR System (Applied Biosystems)
using the following primers (Microsynth, Switzerland): ADRB2: 5’-ACAGGGGAGCAGAGTG
GATA-3’ and 3’- ACAGTACCTTGATGGCCCAC-5’ and GCR: 5’-TGGGGACTCTGAACTTC
CCTG-3’ and 3’- CTGTTGTTGCTGTTGAGGAGC-5’ (Complete primer list available in S1
Protocol). The amplification process consisted of polymerase activation at 95°C for 10 min.,
45 cycles with 15 s of denaturation at 95°C and 1 min. of annealing and elongation at 60°C and a
final elongation step for 1 min. at 60°C. For all samples signals were detected between cycles
24 and 35. Two reference genes (GADPH and PKG1) were used for relative quantification. A
more detailed description of the qPCR protocol is available in S1 Protocol.
Data analysis and statistics
All flow cytometry data was analyzed blinded for the drug condition using FlowJo Software
(Version X 10.0.7). Gating strategies for the analyses are shown in the supporting information
(S2 Fig and S3 Fig). Statistical analyses and data visualization was performed using Prism soft-
ware (Prism 6.0, Graphpad). Group comparisons were performed using t-tests or Kruskal Wal-
lis tests followed by Dunn’s comparisons. Correlation analyses were performed using
Spearman Rank tests.
Results and Discussion
Drug-induced cardiovascular stress responses associate with an
increased proportion of peripheral Natural killer cells
The cardiovascular response and stress hormone levels in the peripheral blood can indicate
stress. MDMA, MPH, and the combination of the two drugs induced an increase in systolic
blood pressure (SBP) and heart rate peaking three hours after drug administration (Fig 1A and
1B). Details to the cardiovascular response in the study subjects have been reported previously
[12]. The MDMA/MPH combination induced the strongest increase in SBP, and MPH alone
induced a SBP increase of lower magnitude than the conditions that included MDMA (Fig
1A). Contrarily, the heart rate was highest in treatment conditions including MPH (Fig 1B).
Since these differences might be linked to different stress hormone profiles induced by the dif-
ferent treatments, levels of cortisol and catecholamines were analyzed and compared with lev-
els measured in placebo treated study subjects. Hormone levels two hours after drug
administration (i.e. at their peak) were compared to the baseline blood draws, which were all
performed at 8 am. All active drug conditions resulted in a comparable, albeit non-significant
increase of norepinephrine at 2 hours (data not shown). The most striking difference between
the drug conditions was an increase in cortisol concentration upon exposure to MDMA
(p< 0.001) or MDMA/MPH (p< 0.0001) compared to placebo or MPH alone (Fig 1C). Corti-
sol levels fell in the placebo and MPH condition, consistent with known circadian changes in
cortisol, given the timing of the blood draws, all starting at 8 am [19]. The increase in epineph-
rine concentrations was higher in individuals exposed to MDMA/MPH (p< 0.0001) than in
those exposed to MDMA alone (p< 0.01) and lowest in participants after MPH intake alone,
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suggesting an additive effect of MDMA and MPH on the epinephrine stress response (Fig 1D).
The cardiovascular stress response (i.e. HR increase and SBP increase) correlated with both,
the epinephrine (HR: p = 0.0035, r = 0.42; SBP: p = 0.0001, r = 0.53), and cortisol increase (HR:
p = 0.0001, r = 0.53; SBP p<0.0001, r = 0.71). Together, the findings suggest that the study con-
ditions resulted in distinct cardiovascular and endocrine stress response profiles.
Acute stress has been linked to a recruitment of NK cells to the peripheral blood in various
models [6]. To test whether the same applies to pharmacological stress induced by MDMA,
MPH or their combination, we monitored the change in lymphocyte subset-distribution at
baseline and three hours after drug administration. This time-point was chosen based on the
stress hormone level peak that occurs around 2–3 hours after drug-intake [11]. We then calcu-
lated the percentage change in T cells (CD4+ and CD8+), B cells and NK cells compared to the
baseline distribution (gating strategy is depicted in S2 Fig). The most striking observation was
a dramatic increase of NK cells within the lymphocyte compartment that was most pro-
nounced upon exposure to combination treatment of MDMA and MPH (p< 0.001 Fig 1E).
The other immune cell subsets were variably decreased (Fig 1F–1H). Pacifici et al. also
reported a comparable and rapid increase of total NK cells in MDMA treated subjects, which
was however not further investigated [14, 20–22]. To enable an immediate response to any
threat it is plausible that early stress-induced adaptations act through cell redistribution, and
preferentially impact innate immunity that can unfold much more rapidly [6, 23].
Because this rapidly occurring redistribution of lymphocyte subsets suggested stress hor-
mone-mediated effects, we next correlated stress hormone levels (2 hours post administration)
Fig 1. Drug-induced stress induces a pronounced cardiovascular responses and NK cell recruitment. (A) Systolic blood pressure (SBP) in mmHg and
(B) heart rate (HR) in beats per minute (bpm) are shown three hours (i.e. one hour after the stress hormone peak) post-adminstration of the study drug
(n = 12). The grey shaded area indicates the normal values. Serum cortisol (C) and epinephrine (D) levels were measured before and two hours post drug
administration and the difference from baseline was calculated. Box plots indicate median and IQR, whiskers indicate range. (E-H) Lymphocyte subset
distribution 3 hours after drug administration was examined (n = 12). Percent change from baseline level to three hours post administration (Δ%) was
calculated for each lymphocyte subset. Mean Δ% and S.E.M is shown for the four main lymphocyte subsets: (E) NK cells (CD3- CD56+), (F) B cells (CD3-
CD19+), (G) CD8 cytotoxic T cells (CD3+ CD8+) and (H) CD4 T helper cells (CD3+ CD4+). Kruskal-Wallis test with Dunn’s correction to test for multiple
comparisons was used (*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001).
doi:10.1371/journal.pone.0145635.g001
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with the individual NK cell increase, irrespective of the treatment. NK cell increase correlated
with the change in epinephrine levels (p = 0.0049, r = 0.44; S1A Fig), but not with the change
of cortisol or norepinephrine (S1B and S1C Fig). Dopamine was only very weakly (median
0.03 nmol/L, IQR -0.03–0.09) and inconstantly increased following any drug administration and
the change in dopamine levels showed no correlation with the change in NK cell frequencies
(data not shown). Similarly, we found no correlation between drug induced neuropsychological
effects -namely changes in activity or emotional excitability- and NK cell redistribution. Taken
together, this hinted at a more pronounced role of epinephrine in NK cell redistribution.
Stress enriches for circulating cytotoxic NK cells with unaltered effector
functions and activation state
Given their strong relative increase upon drug-induced stress, we performed a more detailed
analysis of the specific NK cell subsets and their functionality. Although both cytotoxic
(CD56dim) and immunomodulatory (CD56bright) NK cell subsets increased, the most pro-
nounced effect was detected for CD56dim NK cells upon the combined drug stimulation (Fig
2A). This indicated that CD56dim NK cells were recruited preferentially upon stress. The stron-
ger correlation between the change in CD56dim NK cells and the alteration in epinephrine lev-
els (p = 0.004, r = 0.45, Fig 2B), as compared to the correlation with change in cortisol levels
(Fig 2C, p = 0.041, r = 0.31), further supported this notion. In contrast, we did not detect any
correlation of CD56bright NK cells and hormone levels (data not shown). Interestingly, the shift
in the NK cell subsets did not translate into enhanced NK effector functions against target cells
(Fig 2D). Previous studies variably associated acute stress with enhanced [6], or decreased NK
cell activity [24, 25], which could relate to different assay conditions (e.g. not including human
plasma in the culture media, cryopreservation [26]), some of which were, however, inevitable
in order to test all samples from a donor simultaneously with the same target cell conditions.
Reduced function has moreover been attributed to glucocorticoid-induced epigenetic changes,
which we might have missed by testing NK function within three hours post-stressor [27].
Drug-induced stress consistently associated with a moderate, but significant lower per-cell
expression (i.e. mean fluorescence intensity; MFI) of NKG2D, an NK cell activating receptor
recognizing stress-induced proteins (Fig 2E). This decrease was limited to CD56dim NK cells,
and NKG2D on bulk T cells was slightly increased (data not shown). NKG2D expression on
CD56dim NK cells was inversely correlated with the change in epinephrine levels (Fig 2F,
p< 0.0001, r = -0.59), compared to an again more moderate effect of cortisol (Fig 2G,
p = 0.036, r = -0.32). This NKG2Dlow phenotype might reflect a safety measure preventing an
overshooting NK stimulation that would result in excessive immunopathology [28–31]. Due to
sample availability, we could however not address this hypothesis experimentally. Treatment
of NK cells with synthetic epinephrine and cortisol in vitro dampened NK function, as expected
from the literature [32]. Yet, this NK cell inhibition was independent of NKG2D expression, as
NKG2D was only reduced inconstantly (i.e. six of eleven healthy donors) and showed no corre-
lation with NK function. Moreover, a reduction in NK function was also observed against
721.221 target cells not expressing NKG2D ligands (data not shown). Together, this indicates
that the NKG2Dlow phenotype results from mobilization of these NK cells rather than from a
receptor down-modulation by direct hormone effects.
Inherent expression differences of key surface receptors may explain
preferential recruitment of CD56dim NK cells
Our immunophenotypic data suggested that drug-induced stress associated with the preferen-
tial recruitment of cytotoxic NK cells without substantially affecting their function. Thus, we
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next aimed at defining molecular differences between CD56dim and CD56bright NK cell subsets
that may explain the preferential recruitment of the CD56dim subset. First, we assessed the
expression-profile of receptors previously linked to epinephrine-mediated lymphocyte redistri-
bution, namely high expression of the fractalkine receptor CX3CR1 and low expression of
CD62L [33], in five healthy untreated individuals. The flow cytometry gating strategies are
shown in the supporting information (S3 Fig). Indeed, we found that the CD56dim subset
expressed very high levels of CX3CR1 (Fig 3A), but low levels of CD62L (Fig 3B). This expres-
sion profile was inverse in the CD56bright subset (CX3CR1, p< 0.0001; CD62L, p = 0.001). In
contrast, CD18, an integrin known to bind to ICAMs and thereby enhancing NK cell migration
[34] was slightly more expressed on the CD56dim NK subset (p = 0.008, Fig 3C). Next, we
assessed mRNA and protein levels of the β2-adrenergic receptor (ADRB2) and glucocorticoid
receptor (GCR), i.e. the receptor for epinephrine and cortisol respectively, in the two NK cell
Fig 2. Unaltered NK function but reduced NKG2D expression upon drug-induced stress. (A) Percent change in the two NK cell subsets was calculated
and expressed as mean + S.E.M. (B,C) The percent change of CD3- CD56dim NK cells was correlated to the change in serum epinephrine (B) and cortisol (C)
levels 2 hours p.a. in all drug categories together (n = 44). (D) NK function against K562 target cells was assessed. Changes in IFNγ+ or CD107a+
(degranulation) CD56dim NK cells are shown for each drug category as absolute change in percentage (n = 11, mean + S.E.M). (E) Example histograms of
NKG2DMFI before (grey) and after (black) MPH / MDMA treatment are shown for a donor with a strong (left) and weak (right) response (upper panels). The
numbers indicate the MFI. Absolute change in the MFI of NKG2D expression (n = 12, mean + S.E.M) is displayed for each drug condition (lower left panel).
NKG2DMFI at baseline and 3 hours p.a. is shown separately for all subjects for the condition with a significant difference to placebo (MPH / MDMA) (lower
right panel). The absolute change in MFI of NKG2D was correlated to serum epinephrine (F) and cortisol (G) levels irrespective of drug treatment (n = 44).
Spearman correlation and nonlinear fit were applied for correlation analyses and Kruskal-Wallis test was applied for all group comparisons. *P < 0.05,
**P < 0.01, ***P < 0.001.
doi:10.1371/journal.pone.0145635.g002
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Fig 3. Preferential recruitment of CD56dim NK cells depends on distinct hormone andmigration
receptor expression profiles. Expression of three receptors important in cell adhesion and migration were
assessed by flow cytometry. (A-C) Example stainings gated on CD3- CD56+ lymphocytes are shown for
CX3CR1 (A), CD62L (B) and CD18 (C). The frequency (A, B) or MFI (C) of receptor expression on CD56bright
and CD56dim is indicated (upper panels). Data on freshly derived PBMCs from five healthy, unstressed
donors are summarized (A-C lower panels). (D, E) Expression of the epinephrine receptor (ADRB2) (D) and
the glucocorticoid receptor (GCR) (E) were assessed on CD3- CD56+ lymphocytes by flow cytometry. Isotype
control stainings for ADRB2 and GCR are shown, followed by an example staining (left panels). The MFI of
the two subsets is indicated for CD56bright (upper right corner) and CD56dim NK cell subsets (lower right
corner). Flow cytometric data of the aforementioned five donors is summarized for CD56bright and CD56dim
NK cells (middle panels). Differential ADRB2 and GCR expression on the two NK cell subsets were also
confirmed on mRNA level by measuring relative hormone receptor expression on sorted CD56dim (n = 3) and
CD56bright NK cells (n = 2) by qPCR (right panels). (F) Differential expression of ADRB2 on CD56bright and
Stress-Induced Natural Killer Cell Recruitment
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subsets. Both qPCR- and flow cytometry-based quantification indicated higher expression of
the ADRB2 among CD56dim, compared to the CD56bright, NK cells (p = 0.019 for MFI, Fig
3D). In contrast, the GCR was lower expressed in CD56dim NK cells (p = 0.005 for MFI, Fig
3E). Taken together, and in line with the correlation analyses of the in vivo data, this was sug-
gestive that the CD56dim subset was able to respond more vigorously to epinephrine.
Interestingly, we observed that ADRB2 abundance varied considerably between individuals
(Fig 3D). Therefore, we next tested whether the individual ADRB2 receptor expression on NK
cells might have determined the increase of NK cells in vivo in the clinical study. We first con-
firmed the inter-individual and NK subset-specific variability of ARDB2 expression in seven
subjects included in the clinical stress study (Fig 3F). Importantly, the individual ADRB2
expression was stable over time, as the same donors showed comparable levels on separate
study days (data not shown). Taking advantage of the distinct hormone changes induced by
the different drug conditions (Fig 1C and 1D), epinephrine effects were analyzed by correlat-
ing the change in NK cells and altered ADRB2 expression in the presence (MDMA or MDMA/
MPH group) or absence (MPH) of a concomitant cortisol increase. We found a very strong
correlation between an increase of NK cells and ADRB2 expression in the MPH group
(p = 0.02, r = 0.86), i.e. in absence of a cortisol response. Similar trends, albeit much weaker,
were seen in the other groups (Fig 3F), suggesting that cortisol might contribute to NK cell dis-
tribution in these conditions.
Together, our findings pointed at an important role of epinephrine in the early changes in
the NK cell compartment. Interestingly, in the absence of a cortisol response and at low epi-
nephrine levels (i.e. the MPH treatment condition), NK cell redistribution correlated almost
perfectly with the expression level of the beta-adrenergic receptor. This is in line with a model
of selective catecholamine-dependent regulation of NK cell adhesion to the endothelia [24], as
supported by studies using beta-adrenergic blockade suggesting catecholamines as master reg-
ulators of early stress effects on the immune system [35].
Conclusion
Stress was observed to induce an enrichment of CD56dim NK cells in the peripheral blood,
which associated with a strong epinephrine response. These NK cells expressed a receptor pro-
file that would enable them to rapidly re-distribute to a site of injury or infection, where this
cytotoxic subset could contribute to pathogen defense and wound healing. Differences in hor-
mone receptor expression might explain differences in the magnitude of individual stress
responses. The insights gained from this controlled clinical trial setting, using standardized
stressors that consistently induced distinct stress hormone profiles, support that, in humans,
NK cells can be recruited through epinephrine dependent mechanisms, which may be benefi-
cial e.g. in leukemia or cancer therapy [36]. Our study thus adds a rationale to interventions
that increase endogenous epinephrine levels (i.e. physical activity, MDMA etc. . .) currently
explored e.g. as adjunctive cancer treatments.
Supporting Information
S1 Fig. Correlation of NK cell increase with serum hormone levels. Absolute change in NK
percentage 3 hours after drug administration was correlated to change in concentrations of
CD56dim NK cells was confirmed in study participants 1 hour after placebo treatment (left panel, n = 7).
ADRB2 expression was correlated to the increase in NK cell percentage upon drug administration. Paired t
tests were applied for all group comparisons and Spearman correlation and nonlinear fit for correlation
analyses. *P < 0.05, **P < 0.01, ****P < 0.0001.
doi:10.1371/journal.pone.0145635.g003
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epinephrine (A), cortisol (B) and norepinephrine (C) 2 hours post treatment. Spearman corre-
lation and nonlinear fit were applied.
(TIFF)
S2 Fig. Gating strategy to define lymphocyte and NK cell subsets and to assess NKG2D
expression and IFNγ and CD107a production in NK cell subsets. The top row shows the gat-
ing in order to distinguish B cells, CD4+ and CD8+ T cells. A second panel was used to detect
NK cells, further subdividing them into CD56 dim and CD56 bright NK cells and analyzing
IFNγ and CD107a production (2, middle row, data is shown for CD56 dim). A third panel was
designed to detect NKG2D expression (3, CD314, bottom middle) and a last one to stain for
the glucocorticoid receptor (4, bottom right) on NK subsets. In grey, full stainings are shown
whereas in white, an FMO staining is depicted for NKG2D and an isotype control for GCR. All
data was acquired on an Accuri C6 (Becton Dickinson).
(TIFF)
S3 Fig. Gating strategy for the analysis of adhesion and hormone receptor expression on
NK cell subsets. NK cells were defined by CD16 and CD56 expression on single, live CD3-
cells (upper row). The first panel stained for ADRB2 and CD62L on NK cell subsets whereas
the second panel stained for CX3CR1 and CD18. Example stainings on CD56dim NK cells are
shown in dark grey while isotype control (ADRB2) or fluorescence minus one controls (FMO,
for CD62L, CX3CR1 and CD18) are shown in light grey. All data was acquired on an LSRFor-
tessa flow cytometer (Becton Dickinson).
(TIFF)
S1 Protocol. Detailed RT-PCR protocol for the hormone receptor analysis incl. a complete
list of the primers used.
(DOCX)
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